Literature DB >> 602705

Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.

F H Nielsen, E Honoré, K Kristoffersen, N J Secher, G T Pedersen.   

Abstract

The serum concentrations of triglycerides, cholesterol, and free glycerol were determined in 23 climacteric women, before and after the administration of three different steroid drugs. Each drug was given within a period of 12 weeks (3 cycles). Period I: Norgestrel, 0.5 mg daily from the 12th to 21st day of each cycle. Period II: Oestradiol-valerate (Progynon) 2 mg daily from the 2nd to 21st day of each cycle. Period III: Oestradiol-valerate 2 mg from the 1st to 11th day followed by oestradiol-valerate 2 mg+0.5 mg dl-norgestresl from day 12 to 21 of each cycle (Cycloprogynon). A significant decrease in triglycerides was observed following the administration of norgestrel and Cycloprogynon, whereas oestradiol-valerate had no effect on the triglyceride levels. On the other hand, oestradiol-valerate, following a period of norgestrel, produced an increase in serum cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 602705     DOI: 10.3109/00016347709154994

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Estradiol is a potent inhibitor of the hypotriglyceridemic effect of levonorgestrel in female rats.

Authors:  E H Taves; B M Wolfe
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

2.  Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.

Authors:  B M Wolfe; M W Huff
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.